$ARIA Recent Headlines Ariad takes another pound
Post# of 5325
Posted On: 11/12/2013 6:17:13 PM
$ARIA Recent Headlines
Ariad takes another pounding after leukemia treatment is pulled 12:14 p.m. Oct. 31, 2013 - Russ Britt
H-P has best day in four months on upbeat outlook 3:34 p.m. Oct. 9, 2013 - Sue Chang
Ariad plummets 70% after drug test patients have serious clotting issues 10:38 a.m. Oct. 9, 2013 - Russ Britt
FDA places partial hold on Ariad's Iclusig trials 7:16 a.m. Oct. 9, 2013 - MarketWatch.com
Dan Loeb makes bet on Disney 7:06 p.m. Aug. 14, 2013 - David Benoit
Onyx share surge lifts several boats in biotech harbor, including ETFs 10:33 a.m. July 1, 2013 - Russ Britt
SAC Capital Advisors likes this pharma stock 3:24 p.m. April 18, 2013 - Insider Monkey
Ariad Pharma up 6% to $20.09 10:35 a.m. Dec. 17, 2012 - Steve Gelsi
FDA OKs Iclusig to treat rare types of leukemia 1:06 p.m. Dec. 14, 2012 - MarketWatch.com
Stocks: Investors play the waiting game 8:53 a.m. Dec. 11, 2012 - The Trading Deck
12 biotech stocks hit 52-week highs 2:43 p.m. July 27, 2012 - Val Brickates Kennedy
Three rules for short selling 12:01 a.m. Feb. 2, 2012 - The Trading Deck
Stocks to watch Wednesday: C.R. Bard, Papa John’s 6:52 a.m. Dec. 21, 2011 - MarketWatch
Don't be a fan when investing 8:26 a.m. Dec. 20, 2011 - The Trading Deck
Drug stocks move higher in late trading 2:26 p.m. March 24, 2011 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 5:12 p.m. Jan. 18, 2011 - Kate Gibson
Ariad soars as drug indexes move higher 12:47 p.m. Jan. 18, 2011 - Val Brickates Kennedy
Ariad rallies as drug indexes modestly rise 10:23 a.m. Jan. 18, 2011 - Val Brickates Kennedy
Aria rockets on cancer drug data 9:38 a.m. Jan. 18, 2011 - Val Brickates Kennedy
Ariad jumps on leukemia drug data 3:46 p.m. Dec. 6, 2010 - Val Brickates Kennedy
10-Q: ARIAD PHARMACEUTICALS INC 4:36 p.m. Today - Edgar Online - (EDG = 10Q, 10K)
Ariad Pharmaceuticals Management Discusses Q3 2013 Results - Earnings Call Transcript 2:30 p.m. Today - Seeking Alpha
Sirius XM Will Host Baseball Giant Joe Torre and 2 Other Hot Stocks to Watch 12:14 p.m. Today - Wall St. Cheat Sheet
ARIAD Pharmaceuticals, Inc. Discusses Q3 2013 Results (Webcast) 8:25 a.m. Today - Seeking Alpha
Health-Care Stocks: Where to Find Value 6:07 a.m. Today - Barrons.com
JPMorgan Considers Ban on Trader Chat Rooms and 2 Other Hot Stocks to Watch 12:17 p.m. Nov. 11, 2013 - Wall St. Cheat Sheet
Benzinga's Top #PreMarket Gainers 7:13 a.m. Nov. 11, 2013 - benzinga.com
Shire, Novartis Deals: Pharmaceutical Shakeups Continue 6:55 a.m. Nov. 11, 2013 - 247WallSt.com
EMA's PRAC Updates On The Risks Of Serious Vascular Occlusive Events Associated With Cancer Medicine Iclusig 8:37 a.m. Nov. 8, 2013 - benzinga.com
ARIAD Shares Tumble on Iclusig Woes - Analyst Blog 5:20 p.m. Nov. 7, 2013 - Zacks.com
ARIAD to Cut 40% of US Staff Positions 3:18 p.m. Nov. 7, 2013 - benzinga.com
Ariad Pharmaceuticals (ARIA) Marked As A Dead Cat Bounce Stock 9:45 a.m. Nov. 6, 2013 - TheStreet.com
6 Biotechnology Stocks to Buy Now 5:15 a.m. Nov. 6, 2013 - InvestorPlace.com
Canada Said to Have Blocked BlackBerry Takeover and 2 More Heavily Traded Stocks to Follow 4:59 p.m. Nov. 5, 2013 - Wall St. Cheat Sheet
The Drive Behind Ariad Pharmaceuticals' (ARIA) Partial Recovery 1:51 p.m. Nov. 4, 2013 - TheStreet.com
Ford Sees October Gains, Netflix Rides an Upgrade, and 3 More Hot Stocks 1:52 p.m. Nov. 1, 2013 - Wall St. Cheat Sheet
2013 Biotech Watchlist Update: Companies Climb And Crumble On Catalysts 11:48 a.m. Nov. 1, 2013 - Seeking Alpha
Are You Betting Too Much On Theravance? 11:28 a.m. Nov. 1, 2013 - Seeking Alpha
Analysts: Facebook Could Add $3B in Revenue and 3 More Research Notes to Browse 10:22 a.m. Nov. 1, 2013 - Wall St. Cheat Sheet
Biotech Stock Mailbag: Chelsea's FDA Panel, Ariad's Future, Bio-Bubble Update 6:00 a.m. Nov. 1, 2013 - TheStreet.com
ARIA, DNDN, HSOL and OREX added to NASDAQ Active Stock Watch List at EPR 9:29 a.m. Today - ACCESSWIRE
Shareholder Rights Law Firm Johnson & Weaver, LLP Files Derivative Lawsuit on behalf of ARIAD Pharmaceuticals, Inc. 9:29 a.m. Today - BusinessWire
ARIAD Reports Third Quarter 2013 Financial Results and Announces Significant Expense Reduction 7:35 a.m. Today - BusinessWire
Glancy Binkow & Goldberg Announces a December 9, 2013 Lead Plaintiff Deadline in the Class Action Lawsuit Against ARIAD Pharmaceuticals, Inc. - ARIA 9:10 a.m. Nov. 11, 2013 - GlobeNewswire
News and Updates on ARIA, AFYG and ASAB 1:27 a.m. Nov. 8, 2013 - ACCESSWIRE
ARIAD Announces Reduction in U.S. Workforce as Part of Broad Program to Reduce Operating Expenses 4:05 p.m. Nov. 7, 2013 - BusinessWire
Financial Results and Upcoming Conference Calls - Research Report on Ariad, Idenix, Osiris, InterMune, and Array BioPharma 8:00 a.m. Nov. 6, 2013 - PR Newswire
Harwood Feffer LLP Announces Investigation of Ariad Pharmaceuticals, Inc. 8:10 p.m. Nov. 5, 2013 - PR Newswire
Top Trial Firm Cohen, Placitella & Roth, PC Investigating Ariad Pharmaceuticals, Inc., for Suspending Sales of its Leukemia Drug Iclusig 12:50 p.m. Nov. 5, 2013 - PR Newswire
Stock Price Movement Update, Recognitions, and Financial Results - Research Report on Ariad Pharmaceuticals, Quintiles, Molina Healthcare, Exelixis, and Masimo 8:00 a.m. Nov. 4, 2013 - PR Newswire
Today's Equity Reports on BZNE, ARIA, AXPW and SPDL 2:25 a.m. Nov. 4, 2013 - ACCESSWIRE
Law Offices of Howard G. Smith Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against ARIAD Pharmaceuticals, Inc. 9:32 p.m. Nov. 1, 2013 - BusinessWire
Morning Research: Ariad Pharma Inc., MannKind Corp., Novavax Inc., and Galena Biopharma Inc. 1:30 p.m. Nov. 1, 2013 - PR Newswire
ARIAD Adopts Shareholder Rights Plan to Preserve Valuable Net Operating Loss Carryforwards and Other Tax Benefits 8:35 a.m. Nov. 1, 2013 - BusinessWire
ARIAD Announces Change to the Date of Its Third Quarter 2013 Financial Results Conference Call and Webcast to November 12, 2013 4:30 p.m. Oct. 31, 2013 - BusinessWire
ARIAD Announces Temporary Suspension of Iclusig Marketing in the United States 7:30 a.m. Oct. 31, 2013 - BusinessWire
ARIAD PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against ARIAD Pharmaceuticals, Inc. and Its Board and a Lead Plaintiff Deadline of December 9, 2013 -- ARIA 3:36 p.m. Oct. 30, 2013 - GlobeNewswire
Sector Leaders Briefing & Capital Raise News: Muscle Warfare, Baidu, Herblife, Gilead Sciences and ARIAD 9:08 a.m. Oct. 30, 2013 - PR Newswire
Ariad Pharmaceuticals Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors 3:30 p.m. Oct. 29, 2013 - BusinessWire
Insider Trading Reports for Intel, Charles Schwab, Fusion-IO, J.C. Penney, Bristol-Myers Squibb, and Ariad Pharmaceuticals 8:55 a.m. Oct. 29, 2013 - PR Newswire
Ariad takes another pounding after leukemia treatment is pulled 12:14 p.m. Oct. 31, 2013 - Russ Britt
H-P has best day in four months on upbeat outlook 3:34 p.m. Oct. 9, 2013 - Sue Chang
Ariad plummets 70% after drug test patients have serious clotting issues 10:38 a.m. Oct. 9, 2013 - Russ Britt
FDA places partial hold on Ariad's Iclusig trials 7:16 a.m. Oct. 9, 2013 - MarketWatch.com
Dan Loeb makes bet on Disney 7:06 p.m. Aug. 14, 2013 - David Benoit
Onyx share surge lifts several boats in biotech harbor, including ETFs 10:33 a.m. July 1, 2013 - Russ Britt
SAC Capital Advisors likes this pharma stock 3:24 p.m. April 18, 2013 - Insider Monkey
Ariad Pharma up 6% to $20.09 10:35 a.m. Dec. 17, 2012 - Steve Gelsi
FDA OKs Iclusig to treat rare types of leukemia 1:06 p.m. Dec. 14, 2012 - MarketWatch.com
Stocks: Investors play the waiting game 8:53 a.m. Dec. 11, 2012 - The Trading Deck
12 biotech stocks hit 52-week highs 2:43 p.m. July 27, 2012 - Val Brickates Kennedy
Three rules for short selling 12:01 a.m. Feb. 2, 2012 - The Trading Deck
Stocks to watch Wednesday: C.R. Bard, Papa John’s 6:52 a.m. Dec. 21, 2011 - MarketWatch
Don't be a fan when investing 8:26 a.m. Dec. 20, 2011 - The Trading Deck
Drug stocks move higher in late trading 2:26 p.m. March 24, 2011 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 5:12 p.m. Jan. 18, 2011 - Kate Gibson
Ariad soars as drug indexes move higher 12:47 p.m. Jan. 18, 2011 - Val Brickates Kennedy
Ariad rallies as drug indexes modestly rise 10:23 a.m. Jan. 18, 2011 - Val Brickates Kennedy
Aria rockets on cancer drug data 9:38 a.m. Jan. 18, 2011 - Val Brickates Kennedy
Ariad jumps on leukemia drug data 3:46 p.m. Dec. 6, 2010 - Val Brickates Kennedy
10-Q: ARIAD PHARMACEUTICALS INC 4:36 p.m. Today - Edgar Online - (EDG = 10Q, 10K)
Ariad Pharmaceuticals Management Discusses Q3 2013 Results - Earnings Call Transcript 2:30 p.m. Today - Seeking Alpha
Sirius XM Will Host Baseball Giant Joe Torre and 2 Other Hot Stocks to Watch 12:14 p.m. Today - Wall St. Cheat Sheet
ARIAD Pharmaceuticals, Inc. Discusses Q3 2013 Results (Webcast) 8:25 a.m. Today - Seeking Alpha
Health-Care Stocks: Where to Find Value 6:07 a.m. Today - Barrons.com
JPMorgan Considers Ban on Trader Chat Rooms and 2 Other Hot Stocks to Watch 12:17 p.m. Nov. 11, 2013 - Wall St. Cheat Sheet
Benzinga's Top #PreMarket Gainers 7:13 a.m. Nov. 11, 2013 - benzinga.com
Shire, Novartis Deals: Pharmaceutical Shakeups Continue 6:55 a.m. Nov. 11, 2013 - 247WallSt.com
EMA's PRAC Updates On The Risks Of Serious Vascular Occlusive Events Associated With Cancer Medicine Iclusig 8:37 a.m. Nov. 8, 2013 - benzinga.com
ARIAD Shares Tumble on Iclusig Woes - Analyst Blog 5:20 p.m. Nov. 7, 2013 - Zacks.com
ARIAD to Cut 40% of US Staff Positions 3:18 p.m. Nov. 7, 2013 - benzinga.com
Ariad Pharmaceuticals (ARIA) Marked As A Dead Cat Bounce Stock 9:45 a.m. Nov. 6, 2013 - TheStreet.com
6 Biotechnology Stocks to Buy Now 5:15 a.m. Nov. 6, 2013 - InvestorPlace.com
Canada Said to Have Blocked BlackBerry Takeover and 2 More Heavily Traded Stocks to Follow 4:59 p.m. Nov. 5, 2013 - Wall St. Cheat Sheet
The Drive Behind Ariad Pharmaceuticals' (ARIA) Partial Recovery 1:51 p.m. Nov. 4, 2013 - TheStreet.com
Ford Sees October Gains, Netflix Rides an Upgrade, and 3 More Hot Stocks 1:52 p.m. Nov. 1, 2013 - Wall St. Cheat Sheet
2013 Biotech Watchlist Update: Companies Climb And Crumble On Catalysts 11:48 a.m. Nov. 1, 2013 - Seeking Alpha
Are You Betting Too Much On Theravance? 11:28 a.m. Nov. 1, 2013 - Seeking Alpha
Analysts: Facebook Could Add $3B in Revenue and 3 More Research Notes to Browse 10:22 a.m. Nov. 1, 2013 - Wall St. Cheat Sheet
Biotech Stock Mailbag: Chelsea's FDA Panel, Ariad's Future, Bio-Bubble Update 6:00 a.m. Nov. 1, 2013 - TheStreet.com
ARIA, DNDN, HSOL and OREX added to NASDAQ Active Stock Watch List at EPR 9:29 a.m. Today - ACCESSWIRE
Shareholder Rights Law Firm Johnson & Weaver, LLP Files Derivative Lawsuit on behalf of ARIAD Pharmaceuticals, Inc. 9:29 a.m. Today - BusinessWire
ARIAD Reports Third Quarter 2013 Financial Results and Announces Significant Expense Reduction 7:35 a.m. Today - BusinessWire
Glancy Binkow & Goldberg Announces a December 9, 2013 Lead Plaintiff Deadline in the Class Action Lawsuit Against ARIAD Pharmaceuticals, Inc. - ARIA 9:10 a.m. Nov. 11, 2013 - GlobeNewswire
News and Updates on ARIA, AFYG and ASAB 1:27 a.m. Nov. 8, 2013 - ACCESSWIRE
ARIAD Announces Reduction in U.S. Workforce as Part of Broad Program to Reduce Operating Expenses 4:05 p.m. Nov. 7, 2013 - BusinessWire
Financial Results and Upcoming Conference Calls - Research Report on Ariad, Idenix, Osiris, InterMune, and Array BioPharma 8:00 a.m. Nov. 6, 2013 - PR Newswire
Harwood Feffer LLP Announces Investigation of Ariad Pharmaceuticals, Inc. 8:10 p.m. Nov. 5, 2013 - PR Newswire
Top Trial Firm Cohen, Placitella & Roth, PC Investigating Ariad Pharmaceuticals, Inc., for Suspending Sales of its Leukemia Drug Iclusig 12:50 p.m. Nov. 5, 2013 - PR Newswire
Stock Price Movement Update, Recognitions, and Financial Results - Research Report on Ariad Pharmaceuticals, Quintiles, Molina Healthcare, Exelixis, and Masimo 8:00 a.m. Nov. 4, 2013 - PR Newswire
Today's Equity Reports on BZNE, ARIA, AXPW and SPDL 2:25 a.m. Nov. 4, 2013 - ACCESSWIRE
Law Offices of Howard G. Smith Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against ARIAD Pharmaceuticals, Inc. 9:32 p.m. Nov. 1, 2013 - BusinessWire
Morning Research: Ariad Pharma Inc., MannKind Corp., Novavax Inc., and Galena Biopharma Inc. 1:30 p.m. Nov. 1, 2013 - PR Newswire
ARIAD Adopts Shareholder Rights Plan to Preserve Valuable Net Operating Loss Carryforwards and Other Tax Benefits 8:35 a.m. Nov. 1, 2013 - BusinessWire
ARIAD Announces Change to the Date of Its Third Quarter 2013 Financial Results Conference Call and Webcast to November 12, 2013 4:30 p.m. Oct. 31, 2013 - BusinessWire
ARIAD Announces Temporary Suspension of Iclusig Marketing in the United States 7:30 a.m. Oct. 31, 2013 - BusinessWire
ARIAD PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against ARIAD Pharmaceuticals, Inc. and Its Board and a Lead Plaintiff Deadline of December 9, 2013 -- ARIA 3:36 p.m. Oct. 30, 2013 - GlobeNewswire
Sector Leaders Briefing & Capital Raise News: Muscle Warfare, Baidu, Herblife, Gilead Sciences and ARIAD 9:08 a.m. Oct. 30, 2013 - PR Newswire
Ariad Pharmaceuticals Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors 3:30 p.m. Oct. 29, 2013 - BusinessWire
Insider Trading Reports for Intel, Charles Schwab, Fusion-IO, J.C. Penney, Bristol-Myers Squibb, and Ariad Pharmaceuticals 8:55 a.m. Oct. 29, 2013 - PR Newswire
(0)
(0)Scroll down for more posts ▼